Company Database
Top Healthcare Companies
The most valuable private healthcare and life sciences companies, ranked by their latest post-money valuation.
25 companies · Updated October 18, 2026
| Company | Sector | Stage | Valuation | Latest Funding | Total Funding | Headcount | Momentum | Location | Website | Business Model | Customer Profile |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Healthcare & Life Sciences | Series G | $25B | $555M (Oct 2026) | $3.59B | 1,489 | Waltham, Massachusetts | www.devoted.com | B2C | Government Contracts | ||
| Healthcare & Life Sciences | Growth Equity | $20B | $200M (Jul 2026) | $935M | 124 | Miami, Florida | www.openevidence.com/ | B2B2C | Data as a Service, Subscription SaaS | ||
| Mobility, Transportation & Logistics | Growth Equity | $20B | $1B (Sep 2026) | $3.12B | 1,520 | South San Francisco, California | www.zipline.com/ | B2B | Usage-Based SaaS, Government Contracts, Services & Consulting | ||
| Healthcare & Life Sciences | Series B | $17.5B | $2.1B (May 2026) | $2.7B | 396 | London | www.isomorphiclabs.com/ | B2B | Services & Consulting, Revenue Share | ||
| Healthcare & Life Sciences | Debt | $17B | $4B (Feb 2022) | $49.5M | 9,066 | Boston, Massachusetts | www.athenahealth.com | B2B | Revenue Share, Subscription SaaS, Services & Consulting, Government Contracts | ||
| Healthcare & Life Sciences | VC Round | $12.44B | $120M (Aug 2018) | $658M | 19 | San Diego, California | www.biosplice.com/default.aspx | B2B | Services & Consulting | ||
| Consumer & Commerce | Series E Extension | $11.06B | $62.67M (Mar 2026) | $1.3B | 1,283 | San Francisco, California | www.ouraring.com/ | B2C | Hardware + Subscription, Hardware Sales, Government Contracts | ||
| Healthcare & Life Sciences | Series B | $10.5B | $2B (Jun 2026) | $2.55B | 445 | Cambridge, Massachusetts | www.lila.ai/ | B2B | Usage-Based SaaS, Services & Consulting, Revenue Share | ||
| Healthcare & Life Sciences | Series C Extension | $10.32B | $120M (Sep 2025) | $545M | 216 | Austin, Texas | www.colossal.com | B2B | Services & Consulting, Government Contracts, Data as a Service | ||
| Consumer & Commerce | Series G | $10.1B | $575M (Mar 2026) | $979.39M | 1,084 | Boston, Massachusetts | www.whoop.com | B2C | Hardware + Subscription, Subscription SaaS, Hardware Sales | ||
| Healthcare & Life Sciences | Series E | $9.6B | $650M (May 2025) | $1.26B | 455 | Fremont, California | www.neuralink.com/ | B2B2C | Hardware Sales, Subscription SaaS, Data as a Service | ||
| Healthcare & Life Sciences | VC Round | $7B | $70M (May 2026) | $350.23M | 226 | Mountain View, California | www.athelas.com/ | B2B | Subscription SaaS, Hardware + Subscription, Revenue Share | ||
| Healthcare & Life Sciences | VC Round | $7B | $70M (May 2026) | $1B | 1,561 | Mountain View, California | www.commure.com | B2B | Subscription SaaS, Services & Consulting | ||
| Healthcare & Life Sciences | Series D Extension | $7B | $150M (Feb 2022) | $1.03B | 708 | New York City, New York | www.ro.co/ | B2C | Usage-Based SaaS, Subscription SaaS | ||
| Healthcare & Life Sciences | M&A | $7B | (Jun 2021) | $80.5M | 2,495 | Phoenix, Arizona | www.datavant.com/ | B2B | Subscription SaaS, Usage-Based SaaS, Services & Consulting | ||
| Healthcare & Life Sciences | Series C | $7B | $700M (Jul 2026) | $1.03B | 592 | Stockholm | www.nekohealth.com/ | B2C | Hardware + Subscription, Usage-Based SaaS | ||
| Healthcare & Life Sciences | Series G | $6.7B | $66.88M (Dec 2022) | $2.22B | - | Hangzhou | www.guahao.com/ | B2B2C | Subscription SaaS, Marketplace Commission, Government Contracts, Hardware Sales | ||
| Healthcare & Life Sciences | Private Equity | $6.6B | $200M (Jul 2025) | $453M | 4,505 | Vapi | www.merillife.com/ | B2B | Hardware Sales | ||
| Healthcare & Life Sciences | IPO | $6.5B | $805.9M (Feb 2021) | - | 11 | Beijing | www.safeglp.com/ | B2B | Services & Consulting, Data as a Service, Hardware Sales | ||
| Healthcare & Life Sciences | VC Round | $6.33B | $3B (Jan 2022) | - | 438 | Redwood City, California | www.altoslabs.com/ | B2B | Services & Consulting | ||
| FinTech | Series G | $6.3B | $550M (Jun 2026) | $1.3B | 787 | Paris | www.alan.com/ | B2B2C | Subscription SaaS | ||
| Enterprise Software | Series F | $6.1B | $100M (Nov 2021) | $405.05M | 678 | San Francisco, California | www.benchling.com | B2B | Subscription SaaS, Services & Consulting, Freemium | ||
| Healthcare & Life Sciences | Series B | $6B | $85M (Apr 2024) | $85.28M | 2 | Mountain View, California | www.neurovigil.com/ | B2B | Services & Consulting, Data as a Service | ||
| Healthcare & Life Sciences | Series E | $5.7B | $116M (Sep 2021) | $1.01B | 772 | Brooklyn, New York | www.cityblock.com/ | B2B2C | Revenue Share, Services & Consulting | ||
| Healthcare & Life Sciences | Series G | $5.58B | $235M (Jan 2022) | $891.1M | 2,266 | Burlingame, California | www.lyrahealth.com/ | B2B2C | Subscription SaaS, Usage-Based SaaS |
Companies are classified into this sector based on Caplight sector and vertical tagging, then ranked by most recent post-money valuation.